All In Biotech

Drug Trial Radar · NCT00693199

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

Last checked: Nov 20, 2026Latest source record: Aug 8, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

360

Actual

Start

Jul 2006

Primary completion

Oct 2006

Study completion Oct 2006

Sponsor

Lead sponsor
Anhui Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The University of Science and Technology of China; Peking University First Hospital
First posted
Jun 6, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Male only, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.

Conditions

  • Lower Urinary Tract Symptoms
  • Hypertension

Interventions

  • amlodipineDrug

    amlodipine 5mg once daily for 28 days

  • terazosinDrug

    terazosin 2 mg once daily for 28 days

  • amlodipine plus terazosinDrug

    amlodipine 5 mg plus terazosin 2 mg once daily for 28days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary efficacy outcomes were reductions in blood pressure and International Prostate Symptoms Score (IPSS) and sub-scores.Time frame: 28th day after treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Biomedicine Inistitute of Anhui Medical University

    Hefei, Anhui, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.